{"id":"W7117159139","doi":"10.51731/cjht.2025.1316","title":"Quizartinib (Vanflyta)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Cytarabine; Myeloid leukemia; Reimbursement; Drug; Food and drug administration","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003375967,0.0001830197,0.0003195352,0.0008563322,0.0002185727,0.0006301846,0.0003217435,0.0002512895,0.006583903],"category_scores_gemma":[0.0005799408,0.0000669952,0.0003792963,0.000581277,0.0001165197,0.0002520567,0.0001651593,0.0003932847,0.0009052499],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001195349,"about_ca_system_score_gemma":0.001169314,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0112279,"about_ca_topic_score_gemma":0.05607964,"domain_scores_codex":[0.9998092,0.00003663941,0.00001971469,0.0000268532,0.00008048276,0.00002715209],"domain_scores_gemma":[0.9998684,0.00003030593,0.00003831639,0.000003425102,0.00004190206,0.0000176839],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007062503,0.00006931357,0.0008951537,0.00546128,0.0002644405,0.0001689353,0.00003270141,0.0003827501,0.003553997,0.002312785,0.06389993,0.9222524],"study_design_scores_gemma":[0.0007734126,0.0008235428,0.007851786,0.003629776,0.0006998074,0.001981119,0.00005061649,0.0003738686,0.003693366,0.0006109818,0.9794884,0.00002332905],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.02608964,0.8967905,0.001060454,0.003542399,0.0006131221,0.0002593286,0.003345458,0.0002589833,0.06804008],"genre_scores_gemma":[0.3261837,0.6286663,0.003692761,0.003566536,0.0003566793,0.0001972547,0.005202919,0.00002816803,0.03210567],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.0112279,"threshold_uncertainty_score":0.0223251,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02402637483748301,"score_gpt":0.3171629694084499,"score_spread":0.2931365945709669,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}